Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.
Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSeveral key resources related to alpha-1 antitrypsin deficiency have been removed, including links to MedlinePlus and NIH, which may impact access to important genetic and health information.SummaryDifference4%
- Check21 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added related to alpha-1 antitrypsin deficiency, including links to MedlinePlus and NIH, while the previous version 2.12.1 has been removed.SummaryDifference4%
- Check35 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated to version v2.12.0, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.11.2.SummaryDifference0.2%
- Check64 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference0.8%
Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.